María Candelaria
Martín González
Profesora Contratada Doctora
Hospital de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Gran Canaria Dr. Negrin (18)
2024
-
Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients
Journal of Clinical Medicine, Vol. 13, Núm. 3
-
Mean Platelet Volume Is Related to Cumulative Disease Damage in Patients with Systemic Lupus Erythematosus
Life, Vol. 14, Núm. 4
-
Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 42, Núm. 9, pp. 1773-1780
2023
-
Alpha-Klotho protein in systemic lupus erythematosus
Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 41-47
-
Blood Composite Scores in Patients with Systemic Lupus Erythematosus
Biomedicines, Vol. 11, Núm. 10
-
Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III
Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 67-73
-
Mean Platelet Volume in a Series of 315 Patients with Rheumatoid Arthritis: Relationship with Disease Characteristics, including Subclinical Atherosclerosis and Cardiovascular Comorbidity
Diagnostics, Vol. 13, Núm. 20
-
Red Cell Distribution Width Association with Subclinical Cardiovascular Disease in Patients with Rheumatoid Arthritis
Journal of Clinical Medicine, Vol. 12, Núm. 20
-
Relationship between Disease Characteristics and Circulating Interleukin 6 in a Well-Characterized Cohort of Patients with Systemic Lupus Erythematosus
International Journal of Molecular Sciences, Vol. 24, Núm. 18
-
Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus
Antioxidants, Vol. 12, Núm. 8
-
Relationship of Blood Inflammatory Composite Markers with Cardiovascular Risk Factors and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
Life, Vol. 13, Núm. 7
-
Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients
Biomolecules, Vol. 13, Núm. 8
-
Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients
Biomolecules, Vol. 13, Núm. 1
-
Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
Arthritis Research and Therapy, Vol. 25, Núm. 1
2022
-
Apolipoprotein C-III in patients with systemic lupus erythematosus
Arthritis Research and Therapy, Vol. 24, Núm. 1
-
Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis
Arthritis Research and Therapy, Vol. 24, Núm. 1
-
Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus
Frontiers in Immunology, Vol. 13
-
Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients
Biomolecules, Vol. 12, Núm. 12